SUVmax sheds light on prognosis for patients with NSCLC

02/9/2013 | AuntMinnie.com (free registration)

Maximum standardized uptake value as measured by PET/CT may help improve prediction of progression-free survival in patients with early-stage non-small cell lung cancer undergoing stereotactic body radiation therapy, according to findings presented at an imaging and radiation therapy conference. The study involved patients who had PET/CT imaging with SUVmax assessment before undergoing treatment. SUVmax assessment may allow for more tailored treatment strategies and ultimately better outcomes, a researcher said.

View Full Article in:

AuntMinnie.com (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Assistant General Counsel, Regulatory
Cardinal Health
Waukegan, IL
Chief Executive Officer
UCare Minnesota
Minneapolis, MN